Clinical trial
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 is registered in ClinicalTrials.gov with Senda Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
- Lead sponsor
- Senda Biosciences
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- April 15, 2020
- Completion date
- February 23, 2021
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.